文献速递肝胆胰外科

T3期胰腺腺癌静脉侵犯深度对预后的影响

Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
PubMed 文献 · Surgery · 2017-05-30

该回顾性研究纳入181例T3N0M0/T3N1M0胰腺腺癌胰十二指肠切除术患者,评估静脉侵犯存在及深度的预后价值。

要点

  • 静脉侵犯深度至内膜是T3胰腺腺癌总生存的独立不良预后因素
  • 是否行静脉切除及有无静脉侵犯与生存无显著差异
  • 辅助化疗与显著改善的总生存独立相关

核心结论

  • T3胰腺腺癌静脉侵犯深度至内膜提示生存差,术前识别该因素有助于筛选适合根治性手术的患者。

研究设计与样本

  • 91例行联合静脉切除的胰十二指肠切除术,90例行标准胰十二指肠切除术。
  • 采用单因素和多因素Cox分析评估生存预后因素。

主要发现

  • 91例静脉切除患者中68例(74%)检出病理静脉侵犯。
  • 静脉侵犯深度:外膜25例,中膜28例,内膜15例。
  • 1、3、5、10年总生存率分别为75%、33%、21%、6%。

临床怎么用

  • 对T3胰腺腺癌患者,术前评估静脉侵犯深度至内膜可能有助于筛选根治性手术候选者。
  • 术后病理应关注静脉侵犯深度分层,侵犯至内膜者预后差。
  • 辅助化疗与改善总生存独立相关。

局限性

  • 回顾性研究设计。
  • 样本来自单中心连续病例。
  • 静脉侵犯深度分层样本量较小(外膜25例、中膜28例、内膜15例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Incomplete evaluation of venous invasion has led to conflicting results regarding the prognosis of patients undergoing pancreatectomy with a synchronous venous resection. This study evaluates the prognostic value associated with the presence and the depth of venous invasion in T3 pancreatic adenocarcinoma. METHODS: This study evaluated retrospectively 181 consecutive pancreatoduodenectomies performed for T3N0M0 and T3N1M0 pancreatic adenocarcinomas (stages IIA and IIB) from January 2006 to December 2014. Univariate and multivariate Cox analyses were performed to assess survival prognostic factors. RESULTS: Pancreatoduodenectomies with a segmental venous resection was performed on 91 patients, while 90 other patients had a standard pancreatoduodenectomies without venous resection. Pathologic venous invasion was detected in 68 (74%) of the 91 venous resection patients. Depth of venous invasion was into the adventitia (n = 25), media (n = 28), and intima (n = 15). The overall survival rates at 1, 3, 5, and 10 years were 75%, 33%, 21%, and 6%, respectively. There were no differences in survival between patients undergoing standard pancreatoduodenectomies and pancreatoduodenectomies with venous resection (27 vs 22 months; P = .28) or between patients with and without venous invasion (20 vs 27 months; P = .08). In multivariate analysis, depth of venous invasion into the intima (hazard ratio, 2.25; 95% confidence interval, 1.16-4.34; P = .0001) and adjuvant chemotherapy (hazard ratio, 0.16; 95% confidence interval, 0.09-0.43; P ≤ .0001) were identified as independent prognostic factors of overall survival. CONCLUSION: Depth of venous invasion into the intima indicates poor survival in pancreatic T3 adenocarcinoma. Preoperative identification of this factor could be helpful for better selection of patients for curative operation.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Addeo P, Velten M, Averous G, et al. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. Surgery. 2017. PMID: 28576385. doi:10.1016/j.surg.2017.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。